Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange
- PMID: 29259003
- PMCID: PMC5805490
- DOI: 10.1182/blood-2017-08-803031
Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange
Conflict of interest statement
Conflict-of-interest disclosure: C.G.J., D.W.B., R.H.A., and A.P. state that a patent application has been filed related to diagnostic testing in HIT (Method of Detecting Platelet-Activating Antibodies That Cause Heparin-Induced Thrombocytopenia/Thrombosis; PCT/US14/62591). The remaining authors declare no competing financial interests.
Figures
References
-
- Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost. 2014;40(1):106-114. - PubMed
-
- Greinacher A. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373(3):252-261. - PubMed
-
- Kuter DJ, Konkle BA, Hamza TH, et al. . Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia. Am J Hematol. 2017;92(8):730-738. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
